Finanzwire Finanzwire
Basculer en Français
11166 Companies
246602 Keywords
174550 Articles
133184 Press releases
Headlines Articles Press releases Data4Cure, Inc. Remove
  1. Home
  2. Companies
  3. Data4Cure, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/04/2024 at 03:05, 2 years 4 months ago

    Data4Cure to Present at the BIO International Convention 2024

    Artificial Intelligence BIO International Convention Data4Cure Biomedical Intelligence Cloud Personalized Therapies
  • PRESS RELEASE

    published on 06/04/2024 at 03:00, 2 years 4 months ago

    Data4Cure to Present at the BIO International Convention 2024

    Data4Cure to present at the BIO International Convention 2024 their Biomedical Intelligence Cloud platform, offering insights into disease mechanisms and new drug targets
    Healthcare Innovation Data4Cure Biomedical Data BIO International Convention 2024 Biomedical Intelligence Cloud
    Logo of Data4Cure, Inc.
  • BRIEF

    published on 04/08/2024 at 23:20, 2 years 6 months ago

    Data4Cure to Present Key Research at AACR 2024

    Cancer Research Immunotherapy AACR 2024 Data4Cure Biomedical Data
  • PRESS RELEASE

    published on 04/08/2024 at 23:15, 2 years 6 months ago

    Data4Cure Announces a Late-Breaking Abstract to Be Presented at the 2024 American Association for Cancer Research Annual Meeting

    Data4Cure announces the release of the Single-Cell Immune Checkpoint Inhibition Atlas at AACR 2024, facilitating insights on cancer immunotherapy. CEO highlights integration of high-throughput data for new therapies
    Cancer Research Immunotherapy AACR 2024 Data4Cure Single-cell Atlas
    Logo of Data4Cure, Inc.
Accesswire
  • Published on 10/13/2026 at 15:00, 15 minutes ago

    Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend

  • Published on 10/13/2026 at 14:45, 30 minutes ago

    Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides

  • Published on 10/13/2026 at 14:31, 44 minutes ago

    First Breach Completes First Autonomous Flight of Proprietary Drone Prototype

  • Published on 10/13/2026 at 14:10, 1 hour 5 minutes ago

    NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements

  • Published on 10/13/2026 at 14:00, 1 hour 15 minutes ago

    Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

View all ACCESSWIRE
EQS Group
  • Published on 10/13/2026 at 15:06, 8 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 10/13/2026 at 15:05, 9 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

  • Published on 10/13/2026 at 15:05, 9 minutes ago

    Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats

  • Published on 10/13/2026 at 15:03, 11 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc

  • Published on 10/13/2026 at 15:02, 12 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

View all EQS
Les Echos
  • Published on 10/13/2026 at 09:04, 6 hours 10 minutes ago

    Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards

  • Published on 10/12/2026 at 17:59, 21 hours 15 minutes ago

    Reporting on share buyback transactions carried out between October 7 and October 9, 2026

  • Published on 10/12/2026 at 17:45, 21 hours 30 minutes ago

    Weekly share buyback

  • Published on 10/12/2026 at 17:45, 21 hours 30 minutes ago

    Declaration of transactions on own shares from October 5, 2026 to October 11, 2026

  • Published on 10/12/2026 at 15:47, 23 hours 27 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy